JPRN-jRCT2031210280已完成1 期
SJP-0008 Phase I -QT/QTc evaluation Study in Healthy Japanese Adult Male Subjects
Ohtori Akira0 个研究点目标入组 48 人开始时间: 2021年8月27日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 40age old（—）
- 性别
- Male
入选标准
- •Healthy Japanese male
- •- 20-39 years of age at the time of the informed consent
- •- Other protocol-specified inclusion criteria may apply
排除标准
- •- History or complications of diseases such as the heart, kidneys, liver, and brain that are considered inappropriate for participation in this clinical trial
- •- History or complications of serious drug allergies or food allergies
- •-Judged by the investigator, etc. to be ineligible for this clinical trial
- •-Other protocol-specified exclusion criteria may apply
研究者
相似试验
已完成
不适用
An Open-label Phase 1b QT/QTc Study of JNJ-56021927 (ARN-509) in Subjects With Castration-Resistant Prostate Cancer.10036958prostate cancerNL-OMON47113Johnson & Johnson Pharmaceutical10
已完成
1 期
Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG ParametersConstipationNCT00903747Movetis120
已完成
1 期
A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male SubjectsHealthyNCT02117830Repros Therapeutics Inc.54
已完成
不适用
Study to clinically evaluate the QT/QTc interval prolongation potential of vericiguat in patients with stable coronary artery disease in a 2-arm, placebo-controlled, randomized, double-blind, double-dummy design including a vericiguat multiple-dose part with fixed up-titration periods and moxifloxacin as positive control (for assay sensitivity testing, nested into the placebo treatment)cardiovascular diseaseNL-OMON46553Bayer30
招募中
1 期
A study to investigate the safety and tolerability of intravenous QEQ278 in patients with advanced solid tumorsJPRN-jRCT2031220585Hirano Takamitsu9